Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer.

CONCLUSION: There were lipid metabolomic differences in patients with pancreatic cancer, which could serve as potential tumor markers for pancreatic cancer. PMID: 32638847 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32638847?dopt=Abstract

Source: Acta Cirurgica Brasileira - July 5, 2020 Category: Surgery Authors: Zhou D, Mu D, Cheng M, Dou Y, Zhang X, Feng Z, Qiu G, Yu H, Chen Y, Xu H, Sun J, Zhou L Tags: Acta Cir Bras Source Type: research